101. Seroprevalence, risk factors and genotype distribution for Hepatitis C infection: A study from rural hospital in Maharashtra.
- Author
-
Patil SR, Datkhile KD, Ghorpade MV, Patil SS, and Kakade SV
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cross-Sectional Studies, Disease Transmission, Infectious, Female, Hepatitis C transmission, Hepatitis C Antibodies blood, Humans, India epidemiology, Infant, Infant, Newborn, Male, Middle Aged, RNA, Viral blood, Risk Factors, Young Adult, Genotype, Hepacivirus classification, Hepacivirus isolation & purification, Hepatitis C epidemiology, Hepatitis C virology, Hospitals, Rural, Seroepidemiologic Studies
- Abstract
Background and Objectives: Hepatitis C is global health problem affecting a significant portion of the world's population. Available data in Western Maharashtra on seroprevalence, risk factors and genotype distribution are very limited., Objectives: The present study was carried out to estimate the seroprevalence, factors influencing transmission and distribution of genotype of hepatitis C virus (HCV) in a hospital-based population., Materials and Methods: This was a cross-sectional, hospital-based study. A total of 25193 serum samples were tested for HCV and HBV infection. All samples from HCV antibody-positive patients were subjected for HCV RNA detection and genotype. Chi-square, unpaired t-test, logistic regression analysis was used for statistical analysis., Results: The seroprevalence for anti-HCV-Ab was 0.46%. Backward multivariate logistic regression analysis revealed increasing age; alcoholic, blood transfusion and dialysis were significant risk factors. Of 116 patients with HCV, 8 (6.89%) patients had HCV-HBV co-infection. The most common genotype (61.90%) was 3 followed by Genotype 1 (38.09%)., Conclusions: In the present study, significant risk factors were a history of blood transfusion, habit of alcohol, dialysis. The prevention of HCV infection can be achieved by screening of blood and blood products and creating awareness about risk factors. Since the efficacy of current and new therapies differ by genotype, genotype study is essential.
- Published
- 2017
- Full Text
- View/download PDF